Last Updated : November 30, 2007
Details
FilesGeneric Name:
Aliskiren
Project Status:
Complete
Therapeutic Area:
Hypertension
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Brand Name:
Rasilez
Project Line:
Reimbursement Review
Project Number:
SR0118-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Hypertension
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : November 30, 2007